Biofrontera AG

• Research and Markets: Migraine - Pipeline Review, Q4 2010 Provides Details of Drug Profiles including Botulinum Toxin Type A.

...* Merck & Co., Inc. * Biofrontera AG. * Novartis AG. * Pfizer Inc. * Teva Pharmaceut...

• Business Wire
• January 07, 2011

• Biofrontera Pharmaceuticals and Janssen Pharmaceutica Enter a Research Agreement to Explore Modulation of Nicotinic Receptors in Treatment of Alzheimer's Disease.

Business Editors& Health/Medical Writers BIOWIRE2K LEVERKUSEN, Germany--(BW HealthWire)--Aug. 27, 2001 A research collaboration was announced to...

• Business Wire
• August 27, 2001

• A Drug Pipeline Report of the Central Nervous System Focusing on Migraines: Major Companies & Clinical Trial Intelligence Included.

...Companies Mentioned Include: . * Biofrontera AG . * Ariston Pharmaceuticals, Inc. . * BTG plc ....

• Business Wire
• July 17, 2008

• The Neurotechnology Industry 2006 Report - Market Analysis and Strategic Investment Guide for the Global Neurological Disease and Psychiatric Illness Markets.

...BioFrontera, Cellzome AG, CeNeS Pharmaceuticals, Cephalon, Cep...

• Business Wire
• June 21, 2006

• Research and Markets: Pain Therapeutics - Drugs, Markets and Companies.

...B Braun Medical Inc . Bayer AG . Biofrontera Pharmaceuticals GmbH . Biovail Corporation . Brist...

• Business Wire
• April 22, 2004

• Maven Semantic: Neuropathic Pain Database.

...* Biofrontera Pharmaceuticals GmbH. * Biogen Idec, Inc. * BIOTEK...

• Business Wire
• February 01, 2011

• Neurotechnology Industry Report Says Revenues Grew 10% to $120.5 Billion.

... - BioControl Systems - Biocortech - BioFrontera - Biogen Idec - BioLineRX - Bio-logic Systems - Bi...

• Business Wire
• June 11, 2007